# Dermata Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Apr 7, 2025

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-07
- Accepted by EDGAR: Apr 7, 2025, 21:37 ET
- Period: not reported
- Accession: 0001641172-25-003085
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000164117225003085/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000164117225003085/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000164117225003085/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-003085. Last ingested by Listed: Nov 2, 2026, 18:37 ET. No prices; not investment advice.